Literature DB >> 9127691

Resveratrol: a molecule whose time has come? And gone?

G J Soleas1, E P Diamandis, D M Goldberg.   

Abstract

OBJECTIVES: Resveratrol (3,5,4'-trihydroxystilbene) is the parent compound of a family of molecules, including glucosides and polymers, existing in cis and trans configurations in a narrow range of spermatophytes of which vines, peanuts and pines are the prime representatives. Its synthesis from p-coumaroyl CoA and malonyl CoA is induced by stress, injury, infection or UV-irradiation, and it is classified as a phytoalexin anti-fungicide conferring disease resistance in the plant kingdom.
RESULTS: In vitro, ex vivo and animal experiments have shown that it possesses many biological attributes that favour protection against atherosclerosis, including antioxidant activity, modulation of hepatic apolipoprotein and lipid synthesis, inhibition of platelet aggregation as well as the production of pro-atherogenic eicosanoids by human platelets and neutrophils. Red wine represents its main source in the human diet, and it has been proposed as a major constituent of the polyphenol fraction to which the health benefits of red wine consumption have been attributed.
CONCLUSIONS: The past several years have witnessed intense research devoted to its measurement in wine and the factors likely to promote its enrichment in this beverage. Up to the present, conclusive evidence for its absorption by human subjectsin biologically significant amounts is lacking, and it is questionable (but not yetexcluded) that its powerful and beneficial in vitro activities are reproduced as a consequence of sustained moderate red wine consumption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127691     DOI: 10.1016/s0009-9120(96)00155-5

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  111 in total

1.  trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets.

Authors:  Y Dobrydneva; R L Williams; P F Blackmore
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Engineering the plant cell factory for secondary metabolite production.

Authors:  R Verpoorte; R van der Heijden; J Memelink
Journal:  Transgenic Res       Date:  2000       Impact factor: 2.788

Review 3.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

4.  Response of plasma lipids to dietary cholesterol and wine polyphenols in rats fed polyunsaturated fat diets.

Authors:  L Frémont; M T Gozzelino; A Linard
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

5.  Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography.

Authors:  Zhirong Wang; Tze-chen Hsieh; Zhongtao Zhang; Yuliang Ma; Joseph M Wu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

Review 6.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy.

Authors:  Hui-Wen Yan; Wei-Xin Hu; Jie-Ying Zhang; Ye Wang; Kun Xia; Min-Yuan Peng; Jing Liu
Journal:  Tumour Biol       Date:  2014-02-15

8.  Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.

Authors:  Seon-Min Jeon; Seung-A Lee; Myung-Sook Choi
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

Review 9.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.